chr6-56639604-G-C

Variant summary

Our verdict is Benign. Variant got -10 ACMG points: 1P and 11B. PP3BP4_ModerateBP6BS1BS2

The NM_001374736.1(DST):​c.2705C>G​(p.Ser902Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00173 in 1,613,526 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.0014 ( 2 hom., cov: 32)
Exomes š‘“: 0.0018 ( 4 hom. )

Consequence

DST
NM_001374736.1 missense

Scores

11
4
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:4

Conservation

PhyloP100: 10.0
Variant links:
Genes affected
DST (HGNC:1090): (dystonin) This gene encodes a member of the plakin protein family of adhesion junction plaque proteins. Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene, but the full-length nature of some variants has not been defined. It has been reported that some isoforms are expressed in neural and muscle tissue, anchoring neural intermediate filaments to the actin cytoskeleton, and some isoforms are expressed in epithelial tissue, anchoring keratin-containing intermediate filaments to hemidesmosomes. Consistent with the expression, mice defective for this gene show skin blistering and neurodegeneration. [provided by RefSeq, Mar 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -10 ACMG points.

PP3
Multiple lines of computational evidence support a deleterious effect 8: BayesDel_addAF, BayesDel_noAF, Cadd, Eigen, MutationAssessor, phyloP100way_vertebrate, PROVEAN, REVEL [when max_spliceai, FATHMM_MKL, MetaRNN was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.16644835).
BP6
Variant 6-56639604-G-C is Benign according to our data. Variant chr6-56639604-G-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 474506.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=3, Uncertain_significance=3}.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00137 (208/151954) while in subpopulation NFE AF= 0.00255 (173/67948). AF 95% confidence interval is 0.00224. There are 2 homozygotes in gnomad4. There are 88 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DSTNM_001374736.1 linkc.2705C>G p.Ser902Cys missense_variant Exon 21 of 104 ENST00000680361.1 NP_001361665.1
DSTNM_001723.7 linkc.1094C>G p.Ser365Cys missense_variant Exon 7 of 24 ENST00000370765.11 NP_001714.1 Q03001-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DSTENST00000680361.1 linkc.2705C>G p.Ser902Cys missense_variant Exon 21 of 104 NM_001374736.1 ENSP00000505098.1 A0A7P0T890
DSTENST00000370765.11 linkc.1094C>G p.Ser365Cys missense_variant Exon 7 of 24 1 NM_001723.7 ENSP00000359801.6 Q03001-3

Frequencies

GnomAD3 genomes
AF:
0.00137
AC:
208
AN:
151836
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000363
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000919
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.000284
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00255
Gnomad OTH
AF:
0.000961
GnomAD3 exomes
AF:
0.00113
AC:
283
AN:
251116
Hom.:
0
AF XY:
0.00108
AC XY:
147
AN XY:
135756
show subpopulations
Gnomad AFR exome
AF:
0.000370
Gnomad AMR exome
AF:
0.000231
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000509
Gnomad NFE exome
AF:
0.00223
Gnomad OTH exome
AF:
0.000818
GnomAD4 exome
AF:
0.00177
AC:
2590
AN:
1461572
Hom.:
4
Cov.:
32
AF XY:
0.00171
AC XY:
1240
AN XY:
727106
show subpopulations
Gnomad4 AFR exome
AF:
0.000269
Gnomad4 AMR exome
AF:
0.000157
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.000375
Gnomad4 NFE exome
AF:
0.00225
Gnomad4 OTH exome
AF:
0.000927
GnomAD4 genome
AF:
0.00137
AC:
208
AN:
151954
Hom.:
2
Cov.:
32
AF XY:
0.00119
AC XY:
88
AN XY:
74248
show subpopulations
Gnomad4 AFR
AF:
0.000362
Gnomad4 AMR
AF:
0.000918
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000208
Gnomad4 FIN
AF:
0.000284
Gnomad4 NFE
AF:
0.00255
Gnomad4 OTH
AF:
0.000951
Alfa
AF:
0.00180
Hom.:
0
Bravo
AF:
0.00115
TwinsUK
AF:
0.00297
AC:
11
ALSPAC
AF:
0.00337
AC:
13
ESP6500AA
AF:
0.00182
AC:
8
ESP6500EA
AF:
0.00163
AC:
14
ExAC
AF:
0.00129
AC:
157
EpiCase
AF:
0.00224
EpiControl
AF:
0.00219

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:5Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:5
-
Clinical Genetics, Academic Medical Center
Significance: Uncertain significance
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Apr 06, 2021
Mayo Clinic Laboratories, Mayo Clinic
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Uncertain significance
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Aug 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Feb 23, 2022
GeneDx
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

not specified Benign:1
Feb 05, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: DST c.1094C>G (p.Ser365Cys) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0011 in 251116 control chromosomes, predominantly at a frequency of 0.0022 within the Non-Finnish European subpopulation in the gnomAD database. The observed variant frequency within Non-Finnish European control individuals in the gnomAD database is approximately 2 fold of the estimated maximal expected allele frequency for a pathogenic variant in DST causing Epidermolysis bullosa simplex 3, localized or generalized intermediate, with BP230 deficiency phenotype (0.0011). To our knowledge, no occurrence of c.1094C>G in individuals affected with Epidermolysis bullosa simplex 3, localized or generalized intermediate, with BP230 deficiency and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 474506). Based on the evidence outlined above, the variant was classified as likely benign. -

Hereditary sensory and autonomic neuropathy type 6;C3809470:Epidermolysis bullosa simplex 3, localized or generalized intermediate, with BP230 deficiency Benign:1
Dec 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Inborn genetic diseases Benign:1
Sep 27, 2019
Ambry Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

DST-related disorder Benign:1
Mar 04, 2024
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.18
D
BayesDel_noAF
Pathogenic
0.48
CADD
Pathogenic
26
DANN
Uncertain
0.99
DEOGEN2
Benign
0.18
.;.;.;.;T;.;T;.;T
Eigen
Pathogenic
1.0
Eigen_PC
Pathogenic
0.98
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Pathogenic
0.98
D;D;D;D;D;D;D;D;D
M_CAP
Uncertain
0.24
D
MetaRNN
Benign
0.17
T;T;T;T;T;T;T;T;T
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
2.9
.;.;.;M;.;.;.;.;.
PrimateAI
Uncertain
0.61
T
PROVEAN
Pathogenic
-4.5
D;D;.;D;D;D;D;D;D
REVEL
Pathogenic
0.72
Sift
Pathogenic
0.0
D;D;.;D;D;D;D;D;D
Sift4G
Uncertain
0.0020
.;.;.;.;.;D;D;D;D
Polyphen
1.0
D;.;.;.;.;D;.;D;D
Vest4
0.73
MVP
0.91
MPC
0.56
ClinPred
0.12
T
GERP RS
5.5
gMVP
0.70

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.17
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs138553142; hg19: chr6-56504402; COSMIC: COSV99056342; COSMIC: COSV99056342; API